[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@OzmosiHealth "🚀🚨 BIOPHARM CATALYST ALERT 📆 $NBIX Neurocrine will present Phase X Depressive Disorder Major Data for Osavampator (AMPA Modulator - Small Molecule) tomorrow 👀"
X Link @OzmosiHealth 2025-09-18T11:12Z 2779 followers, XXX engagements

"$GILD Gilead Sciences announced they will present Phase X Triple Negative Breast Cancer results on 2025-10-19 for Sacituzumab govitecan More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2780 followers, XXX engagements

"$BMY Bristol-Myers Squibb announced they will present Phase X Ovarian Cancer results on 2025-10-19 for Izalontamab brengitecan More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2780 followers, XXX engagements

"$LYRA +4.48% today as Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase X ENLIGHTEN X Study More Info:"
X Link @OzmosiHealth 2025-10-06T13:47Z 2780 followers, XXX engagements

"$INCY Incyte announced they will present Phase X Hidradenitis Suppurativa results on 2025-09-17 for Povorcitinib More Info:"
X Link @OzmosiHealth 2025-09-11T20:20Z 2779 followers, XXX engagements

"$MSCLF Satellos Bioscience presented Phase X Muscular Dystrophy Duchenne results on 2025-10-10 for SAT-3247 More Info:"
X Link @OzmosiHealth 2025-10-13T20:27Z 2779 followers, XXX engagements

"$RNA Avidity Biosciences announced they will present Phase X Muscular Dystrophy Duchenne results on 2025-10-08 for Delpacibart zotadirsen More Info:"
X Link @OzmosiHealth 2025-10-08T01:56Z 2776 followers, XXX engagements

"$IPH as Innate Pharma to Host Analyst and Investor Event on Lacutamab on October XX 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2779 followers, XXX engagements

"$MRUS +0.53% today as Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2779 followers, XXX engagements

"$SRPT Sarepta announced they will present Phase X Muscular DystrophiesMuscular Dystrophy Duchenne results on 2025-10-11 for Delandistrogene moxeparvovec More Info:"
X Link @OzmosiHealth 2025-10-06T20:04Z 2770 followers, 1562 engagements

"$SLS +6.30% today as SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2780 followers, XXX engagements

"$CYTK Cytokinetics presented Phase X Cardiomyopathy Hypertrophic results on 2025-09-29 for Aficamten More Info:"
X Link @OzmosiHealth 2025-10-01T00:00Z 2779 followers, XXX engagements

"$DYN Dyne Therapeutics gets FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy. More Info: $XBI $IBB $XPH $PPH"
X Link @OzmosiHealth 2025-08-04T11:32Z 2770 followers, XXX engagements

"$IMNN +2.61% today as IMUNON to Present Phase X Ovarian Cancer Study of IMNN-001 at ESMO Congress More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2779 followers, XXX engagements

"$NUVL +1.86% today as Nuvalent to Present New Preclinical Data for HER2-Selective Inhibitor NVL-330 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2779 followers, XXX engagements

"$CGEN Compugen announced they will present Phase X Ovarian Cancer results on 2025-10-18 for COM-701 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2780 followers, XXX engagements

"$LLY +0.30% today as Lilly's oral GLP-1 orforglipron demonstrated superior glycemic control in two successful Phase X trials reconfirming its potential as a foundational treatment in type X diabetes More Info:"
X Link @OzmosiHealth 2025-10-15T13:49Z 2780 followers, XXX engagements

"Intercept Pharma pulls Ocaliva from US market due to serious liver issues deaths in PBC patients. Nine-year run plagued by warnings limited use failed expansion. New treatments reshaping PBC market. Gileads Livdelzi Ipsens Iqirvo and Zydus saroglitazar on the rise. #healthcare #pharma"
X Link @OzmosiHealth 2025-09-12T15:14Z 2779 followers, XXX engagements

"$EVAX +2.74% today as Evaxion to present a breadth of data from phase X trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2779 followers, XXX engagements

"$VTRS +1.67% today as Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection More Info:"
X Link @OzmosiHealth 2025-09-17T14:07Z 2774 followers, XXX engagements

"$REGMY as 2025 ACR Abstract Released Exciting Data from Telitacicept's Phase III Clinical Study in Sjgren's Syndrome in China More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2779 followers, XXX engagements

"$PGEN +0.16% today as Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2777 followers, XXX engagements

"$CDTX -XXXX% today as Cidara Therapeutics to Present Late-Breaking Clinical Phase X Data on CD388 at ID Week 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2779 followers, XXX engagements

"$GNPX +14.90% today as Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2778 followers, XXX engagements

"$MCRB +0.49% today as Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025 Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2780 followers, XXX engagements

"$RPTX Repare Therapeutics announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-25 for RP-1664 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2780 followers, XXX engagements

"Excellergy launches with $70M Series A funding to advance its pipeline focused on effector cell response therapies"
X Link @OzmosiHealth 2025-10-13T13:26Z 2779 followers, XXX engagements

"$BMY Bristol-Myers Squibb announced they will present Phase X Nasopharyngeal Cancer results on 2025-10-19 for Izalontamab brengitecan More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2779 followers, XXX engagements

"$RYTM PDUFA goal date: Dec. XX 2025 set for priority review of setmelanotide treatment for acquired hypothalamic obesity. More Info:"
X Link @OzmosiHealth 2025-08-21T20:04Z 2778 followers, XXX engagements

"$NBIX -XXXX% today as Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden More Info:"
X Link @OzmosiHealth 2025-09-23T13:45Z 2779 followers, XXX engagements

"$CDTX Cidara announced they will present Phase X Influenza Human results on 2025-10-20 for CD-388 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2780 followers, XXX engagements

"$CYDY +5.25% today as CytoDyn to Present on Leronlimab Induction of PD-L1 and Immune Checkpoint Inhibitor Responses in Metastatic Triple-Negative Breast Cancer at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity More Info:"
X Link @OzmosiHealth 2025-09-25T13:48Z 2779 followers, XXX engagements

"Lillys oral GLP-1 orforglipron outperformed Novos Rybelsus in Phase III on glucose control and weight loss when paired with AstraZenecas Farxiga"
X Link @OzmosiHealth 2025-10-15T17:36Z 2780 followers, XXX engagements

"$GMAB -XXXX% today as Genmab Announces Net Sales of DARZALEX (daratumumab) for Third Quarter of 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2780 followers, XXX engagements

"$PLX Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results"
X Link @OzmosiHealth 2025-08-14T16:13Z 2779 followers, XXX engagements

"$NCNA -XXXX% today as NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2777 followers, XXX engagements

"$BMY Bristol-Myers Squibb announced they will present Phase X Colorectal Cancer results on 2025-10-20 for Nivolumab More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2779 followers, XXX engagements

"$AB +0.81% today as AB Science will hold a virtual conference on Thursday October XX 2025 from 2pm to 3pm CET to provide an update on the Phase X study with AB8939 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2778 followers, XX engagements

"$PFE +0.04% today as TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2777 followers, XXX engagements

"$BRCTF as Leqembi Iqlik (lecanemab-irmb) selected by TIME as one of the best innovations of 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2779 followers, XXX engagements

"$ZLAB Zai Lab announced they will present Phase X Small Cell Lung Cancer results on 2025-10-24 for Zocilurtatug pelitecan More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2779 followers, XXX engagements

"$PALI -XXXXX% today as Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2778 followers, XXX engagements

"$CYTK PDUFA Summary: Cytokinetics misled investors about FDA approval timeline for Aficamten leading to stock price inflation and losses. More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2779 followers, XXX engagements

"$CGEN +12.61% today as Compugen to Present Pooled Analysis of COM701 in Three Phase X Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2779 followers, XXX engagements

"$ZNTL -XXXX% today as Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2779 followers, XXX engagements

"$APRE +4.03% today as Aprea Therapeutics Establishes Recommended Phase X Dose (RP2D) for ATRN-119 Considering Combination Therapies More Info:"
X Link @OzmosiHealth 2025-10-15T13:49Z 2780 followers, XXX engagements

"$CADL -XXXX% today as Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2779 followers, XXX engagements

"$ASMB Assembly Biosciences presented Phase X Sexually Transmitted DiseasesHerpes Simplex results on 2025-10-10 for ABI-5366 More Info:"
X Link @OzmosiHealth 2025-10-13T20:27Z 2777 followers, XXX engagements

"$NBIX Neurocrine presented Phase X Huntington Disease results on 2025-10-06 for Valbenazine More Info:"
X Link @OzmosiHealth 2025-10-08T01:56Z 2779 followers, XXX engagements

"$GILD Gilead Sciences announced they will present Phase X Esophageal CancerGastrointestinal Cancer results on 2025-10-18 for Zimberelimab More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2779 followers, XXX engagements

"$PALI -XXXX% today as Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108 More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2779 followers, XXX engagements

"$AGIO FDA extended PDUFA goal date for Agios Pharmaceuticals' drug Pyrukynd by X months to December X 2025. More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2779 followers, XXX engagements

"$DNLI -XXXX% today as Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome) More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2778 followers, XXX engagements

"$TSHA +39.18% today as Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome More Info:"
X Link @OzmosiHealth 2025-10-02T13:59Z 2769 followers, XXX engagements

"$LLY -XXXX% today as Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2779 followers, XXX engagements

"$GUD as Knight Therapeutics Announces Relaunch of MYFEMBREE in Canada More Info:"
X Link @OzmosiHealth 2025-10-07T13:51Z 2779 followers, XXX engagements

"$ANAB +5.29% today as Anaptys Announces Late-Breaking Oral Presentation of Complete Phase 2b Data for Rosnilimab in Rheumatoid Arthritis at Upcoming ACR Convergence 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2778 followers, XXX engagements

"$NBIX Neurocrine presented Phase X Depressive Disorder Major results on 2025-09-22 for Osavampator More Info:"
X Link @OzmosiHealth 2025-09-23T20:27Z 2779 followers, XXX engagements

"$KRYS +0.38% today as Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2778 followers, XXX engagements

"$NBIX -XXXX% today as Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA (valbenazine) Capsules for Huntington's Disease Chorea More Info:"
X Link @OzmosiHealth 2025-10-06T13:47Z 2779 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $SRPT Sarepta will present Phase X Muscular DystrophiesMuscular Dystrophy Duchenne Data for Delandistrogene moxeparvovec (Gene TherapyDMD - Gene Therapy) tomorrow 👀"
X Link @OzmosiHealth 2025-10-10T11:12Z 2778 followers, 1359 engagements

"$SPRO +0.18% today as Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2777 followers, XXX engagements

"$CERO -XXXX% today as CERo Therapeutics Announces Completion of First Cohort of Phase X Clinical Trial of CER-1236 in AML More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2779 followers, XXX engagements

"$SLS Sellas Life Sciences announced they will present Preclinical T-Cell Peripheral Lymphoma results on 2025-10-18 for Tambiciclib More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2780 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ACAD Acadia will present Preclinical Essential Tremor Data for SAN-711 (GABRA3 Modulator - Small Molecule) tomorrow 👀"
X Link @OzmosiHealth 2025-10-07T11:12Z 2770 followers, XXX engagements

"Pelage Pharmaceuticals raised $120M Series B to develop PP405 a regenerative hair-loss therapy"
X Link @OzmosiHealth 2025-10-15T17:36Z 2780 followers, XXX engagements

"$SNY +0.10% today as Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase X study demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors More Info:"
X Link @OzmosiHealth 2025-10-08T13:46Z 2769 followers, XXX engagements

"$ALXO ALX Oncology announced they will present Phase X Esophageal CancerGastrointestinal Cancer results on 2025-11-08 for Evorpacept More Info:"
X Link @OzmosiHealth 2025-10-06T20:04Z 2774 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $INSM Insmed will present Phase X Hypertension Pulmonary Data for Treprostinil (PGI2 Agonist - Small Molecule) tomorrow 👀"
X Link @OzmosiHealth 2025-09-29T11:12Z 2779 followers, XXX engagements

"Pharma/Biotech Highlights: $MNKD: MannKind expands patent portfolio with Clofazimine. $PHAT: FDA approves Phathom's Vonoprazan tablets. $BMY: EMA approves Bristol Myers Squibb's Opdivo. $DCPH: Positive Phase X results for Vimseltinib"
X Link @OzmosiHealth 2023-10-30T20:35Z 2770 followers, XXX engagements

"$ABSI +21.57% today as Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December XX 2025; Announces Accelerated Initiation of Phase 1/2a Trial More Info:"
X Link @OzmosiHealth 2025-10-15T13:49Z 2780 followers, XXX engagements

"$BMRN Biomarin presented Phase X Achondroplasia results on 2025-09-08 for Vosoritide More Info:"
X Link @OzmosiHealth 2025-09-09T20:18Z 2779 followers, XXX engagements

"$BCTX BriaCell announced they will present Phase X Breast Cancer results on 2025-10-20 for SV-BR-1-GM More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2779 followers, XXX engagements

"$OMER +142.73% today as Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros' clinical-stage MASP-3 inhibitor zaltenibart (OMS906) More Info:"
X Link @OzmosiHealth 2025-10-15T13:49Z 2780 followers, XXX engagements

"$PMVP PMV Pharmaceuticals announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-24 for Rezatapopt More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2779 followers, XXX engagements

"$LEGN Legend Biotech Appoints Carlos Santos as Chief Financial Officer"
X Link @OzmosiHealth 2025-08-18T20:45Z 2774 followers, XXX engagements

"$ATXS Astria Therapeutics partners with Kaken Pharmaceutical to develop and sell Navenibart for HAE in Japan. More Info: $XBI $IBB $XPH $PPH"
X Link @OzmosiHealth 2025-08-06T12:34Z 2774 followers, XXX engagements

"$OSE as OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED a Phase X Clinical Trial Evaluating Tedopi in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer More Info:"
X Link @OzmosiHealth 2025-09-11T20:20Z 2779 followers, XXX engagements

"$ABEO -XXXX% today as Abeona Therapeutics Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2777 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $MRK Merck will present Phase X HIV Infections Data for Doravirine (NNRT Inhibitor - Small Molecule) tomorrow 👀"
X Link @OzmosiHealth 2025-10-15T11:12Z 2779 followers, XXX engagements

"$BLTE +1.08% today as Belite Bio Announces China NMPA Agrees to New Drug Application with Priority Review based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant More Info:"
X Link @OzmosiHealth 2025-10-15T13:49Z 2779 followers, XXX engagements

"$FDMT -XXXX% today as 4DMT Advances 4D-710 to Phase X with Additional Funding and Support from the Cystic Fibrosis Foundation More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2778 followers, XXX engagements

"$PMVP -XXXX% today as PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase X Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2779 followers, XXX engagements

"$ARMP -XXXX% today as Armata Pharmaceuticals to Present Late-Breaking Clinical Data highlighting its Staphylococcus aureus Bacteriophage Cocktail AP-SA02 at IDWeek 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2777 followers, XX engagements

"$ZYME Zymeworks announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-23 for ZW-191 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2780 followers, XXX engagements

"$BAYRY Bayer presented Phase X Muscular Dystrophies Limb-Girdle results on 2025-10-10 for LION-101 More Info:"
X Link @OzmosiHealth 2025-10-13T20:27Z 2777 followers, XXX engagements

"$TNXP +2.49% today as Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb TNX-1500 at the 61st Annual Congress of the Japan Society for Transplantation More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2779 followers, XXX engagements

"$ALNY +0.05% today as Alnylam Announces First Patient Dosed in ZENITH Global Phase X Cardiovascular Outcomes Trial of Zilebesiran More Info:"
X Link @OzmosiHealth 2025-10-01T13:42Z 2768 followers, XXX engagements

"$GILD Gilead Sciences announced they will present Phase X Esophageal CancerGastrointestinal Cancer results on 2025-10-18 for Domvanalimab More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2779 followers, XXX engagements

"$ATOS -XXXX% today as Atossa Advances Global Patent Strategy for Z-Endoxifen with New Protection in Israel and Ongoing Renewals More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2779 followers, XXX engagements

"Novo Nordisk is shutting down its cell therapy R&D unit as part of a major restructuring under new CEO Mike Doustdar"
X Link @OzmosiHealth 2025-10-13T13:26Z 2779 followers, XXX engagements

"$ABBV +0.46% today as U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ (upadacitinib) for the Treatment of Inflammatory Bowel Disease More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2777 followers, XXX engagements

"$EVAX Evaxion Biotech announced they will present Phase X Melanoma results on 2025-10-17 for EVX-01 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2780 followers, XXX engagements

"$ANL Adlai Nortye announced they will present Preclinical Oncology Solid Tumor Unspecified results on 2025-10-25 for AN-4035 More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2778 followers, XX engagements

"$CYTK PDUFA Summary: FDA extended action date for Aficamten NDA to December XX 2025. Stock price fell on disclosure. More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2779 followers, XXX engagements

"$RNAZ +10.43% today as TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2777 followers, XXX engagements

"$CYTK Cytokinetics faced a setback when the U.S. FDA delayed approval for aficamten beyond the expected September XX 2025 PDUFA date. More Info:"
X Link @OzmosiHealth 2025-10-06T20:04Z 2779 followers, XXX engagements

"$BNR +1.06% today as Burning Rock's OncoGuide OncoScreen Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer More Info:"
X Link @OzmosiHealth 2025-09-24T13:53Z 2779 followers, XXX engagements

"$ONC +2.86% today as BeOne Medicines' Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2779 followers, XXX engagements

"$VOR -XXXX% today as Telitacicept Demonstrates Clinically Meaningful and Statistically Significant Impact on ESSDAI Compared to Placebo in Late-Breaking China Phase X Results in Primary Sjgren's Disease at ACR 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2780 followers, XXX engagements

"$LYRA Lyra Therapeutics announced they will present Phase X Sinusitis results on 2025-10-13 for Mometasone furoate More Info:"
X Link @OzmosiHealth 2025-10-08T01:56Z 2779 followers, XXX engagements

"Daily $XBI Summary $ATYR +15% $MLYS +3% $CDTX +3% $NRIX -X% $BHVN -X% $SYRE -4%"
X Link @OzmosiHealth 2025-10-10T14:57Z 2779 followers, XXX engagements

"$BMY Bristol-Myers Squibb announced they will present Phase X Non-Small-Cell Lung Cancer results on 2025-10-17 for Izalontamab brengitecan More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2779 followers, XXX engagements

"$RARE Ultragenyx presented Phase X Glycogen Storage Disease Type Ia results on 2025-09-08 for Pariglasgene brecaparvovec More Info:"
X Link @OzmosiHealth 2025-09-09T20:19Z 2770 followers, XXX engagements

"$PYXS Pyxis Oncology announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-18 for Micvotabart pelidotin More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2780 followers, XXX engagements

"$TOVX Theriva Biologics announced they will present Phase X Pancreatic Cancer results on 2025-10-20 for Zabilugene almadenorepvec More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2780 followers, XXX engagements

"$IMAB +1.64% today as I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2779 followers, XXX engagements

"$NUVL Nuvalent announced they will present Preclinical Oncology Solid Tumor Unspecified results on 2025-10-24 for NVL-330 More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2779 followers, XXX engagements

"$MRUS -XXXX% today as Merus Announces Publication of an Abstract on Petosemtamab in Metastatic Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2779 followers, XXX engagements

"$BIIB -XXXX% today as LEQEMBI (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Australia More Info:"
X Link @OzmosiHealth 2025-09-24T13:53Z 2779 followers, XXX engagements

"$GYRE -XXXX% today as Gyre Therapeutics to Present Results from Positive Phase X Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLDThe Liver Meeting 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2779 followers, XXX engagements

"Candel secures a $XXX M loan (with $XX M upfront) to launch Phase III testing of its immunotherapy CAN-2409 in NSCLC"
X Link @OzmosiHealth 2025-10-15T17:36Z 2780 followers, XXX engagements

"$BCAX +3.35% today as Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2778 followers, XXX engagements

"$SGMT -XXXX% today as Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2780 followers, XXX engagements

"$ZLAB +3.61% today as Zai Lab Announces Oral Presentation of Updated Data from Global Phase X Trial of Zocilurtatug Pelitecan (ZL-1310) a Potential First-in-Class DLL3-Targeted ADC at 2025 AACR-NCI-EORTC Conference More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2779 followers, XXX engagements

"$TNG as Transgene and BioInvent to Present Translational Data and Updated Clinical Results on Armed Oncolytic Virus BT-001 at ESMO 2025 More Info:"
X Link @OzmosiHealth 2025-10-13T15:06Z 2779 followers, XXX engagements

"$LPAA -XXXX% today as Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome More Info:"
X Link @OzmosiHealth 2025-10-15T13:49Z 2779 followers, XX engagements

"$GUD as Knight Therapeutics Announces Relaunch of ORGOVYX in Canada More Info:"
X Link @OzmosiHealth 2025-10-07T13:51Z 2779 followers, XXX engagements

"$ZNTL Zentalis Pharmaceuticals announced they will present Phase X Oncology Solid Tumor UnspecifiedGastrointestinal Cancer results on 2025-10-24 for Azenosertib More Info:"
X Link @OzmosiHealth 2025-10-14T21:49Z 2779 followers, XXX engagements

"$XNCR -XXXXX% today as Xencor Announces Presentation of Initial Phase X Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"
X Link @OzmosiHealth 2025-10-14T21:37Z 2780 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $LYRA Lyra Therapeutics will present Phase X Sinusitis Data for Mometasone furoate (Corticosteroid Hormone Receptor Agonist - Small Molecule) tomorrow 👀"
X Link @OzmosiHealth 2025-10-12T11:12Z 2778 followers, XXX engagements

"$PLX Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference"
X Link @OzmosiHealth 2025-09-02T16:38Z 2779 followers, XXX engagements

"$CORT +1.40% today as Corcept Submits Marketing Authorization Application to European Medicines Agency for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2780 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $MRK Merck will present Phase X HIV Infections Data for Islatravir (NRT Inhibitor - Small Molecule) tomorrow 👀"
X Link @OzmosiHealth 2025-10-15T11:12Z 2780 followers, XXX engagements

"$KYMR +2.76% today as Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-621 a First-In-Class Oral STAT6 Degrader at the European Academy of Dermatology & Venereology and European Respiratory Society Congresses More Info:"
X Link @OzmosiHealth 2025-09-17T14:07Z 2769 followers, XXX engagements

"$JNJ Johnson & Johnson presented Phase X Depressive Disorder Major results on 2025-10-12 for Lumateperone More Info:"
X Link @OzmosiHealth 2025-10-13T20:27Z 2777 followers, XXX engagements

"US government shutdown prompts reductions in force (RIFs) at the Department of Health & Human Services"
X Link @OzmosiHealth 2025-10-13T13:26Z 2777 followers, XXX engagements

"$ENVB +15.46% today as Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin Recently Acquired by AbbVie in $XXX Billion Deal More Info:"
X Link @OzmosiHealth 2025-10-15T13:49Z 2779 followers, XXX engagements

"$TSHA +0.89% today as Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting More Info:"
X Link @OzmosiHealth 2025-10-09T13:39Z 2768 followers, XXX engagements

"$AKRO Akero announced they will present Phase X Non-alcoholic Steatohepatitis results on 2025-11-09 for Efruxifermin More Info:"
X Link @OzmosiHealth 2025-10-08T20:06Z 2770 followers, XXX engagements

"$LXRX +1.39% today as Lexicon Pharmaceuticals Presents Additional Pilavapadin Data in Diabetic Peripheral Neuropathic Pain at 19th Annual Pain Therapeutics Summit More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2780 followers, XXX engagements

"Regeneron is preparing an FDA submission for DB-OTO its gene therapy for profound genetic hearing loss following updated trial data"
X Link @OzmosiHealth 2025-10-13T13:26Z 2775 followers, XXX engagements

"$ZYME +0.42% today as Zymeworks to Present Clinical Data from the Phase X trial of ZW191 an Antibody-Drug Conjugate Targeting Folate Receptor- at AACR-NCI-EORTC International Conference More Info:"
X Link @OzmosiHealth 2025-10-13T20:14Z 2779 followers, XXX engagements

"$ANAB AnaptysBio announced they will present Phase X Arthritis Rheumatoid results on 2025-10-29 for Rosnilimab More Info:"
X Link @OzmosiHealth 2025-10-14T21:48Z 2779 followers, XXX engagements

"$SXTP -XXXX% today as XX Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study More Info:"
X Link @OzmosiHealth 2025-10-15T13:49Z 2780 followers, XXX engagements

"🚀🚨 BIOPHARM CATALYST ALERT 📆 $CYTK Cytokinetics will present Phase X Cardiomyopathy Hypertrophic Data for Aficamten (MYBPC3 Inhibitor - Small Molecule) tomorrow 👀"
X Link @OzmosiHealth 2025-09-27T11:12Z 2779 followers, XXX engagements

"$DTIL -XXXX% today as Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2780 followers, XXX engagements

"$AUPH +0.93% today as Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025 More Info:"
X Link @OzmosiHealth 2025-10-15T13:49Z 2780 followers, XXX engagements

"$CRBP +0.28% today as Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025 More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2779 followers, XXX engagements

"$CDTX Cidara announced they will present Phase X Influenza Human results on 2025-10-23 for CD-388 More Info:"
X Link @OzmosiHealth 2025-10-13T20:27Z 2779 followers, XXX engagements

"$TBPH +1.87% today as Theravance Biopharma to Present New Analyses Highlighting YUPELRI (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting More Info:"
X Link @OzmosiHealth 2025-10-14T15:06Z 2777 followers, XX engagements

"$INCY +1.20% today as Incyte Announces New 24-Week Phase X Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 2025 More Info:"
X Link @OzmosiHealth 2025-09-17T14:07Z 2774 followers, XXX engagements